S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ALNY Alnylam Pharmaceuticals Inc

243.86

0.00 (0.00%)

Pre Market

Last Updated: 21:00:02

Delayed by 15 minutes

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Alnylam Pharmaceuticals (NASDAQ:ALNY)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Alnylam Pharmaceuticals Charts.

Alnylam Pharmaceuticals (NASDAQ:ALNY)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Alnylam Pharmaceuticals Charts.

Alnylam Pharmaceuticals Inc News

Alnylam Highlights Significant Pipeline Progress and Platform Innovation at R&D Day
Tuesday 25 February 2025 (2 days ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 19 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 19 February 2025 (1 week ago) • Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Friday 14 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Friday 14 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 14 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Period Progress
Friday 14 February 2025 (2 weeks ago) • Business Wire

Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2024 Financial Results
Friday 31 January 2025 (4 weeks ago) • Business Wire

More Alnylam Pharmaceuticals Inc News Articles

Vaneckvectors iboxx Eur ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions